Lupin slips 9%, hits 2-year low on disappointing March quarter results

Shares of Lupin hit two-year low of Rs 622 after they fell 9 per cent on the BSE in Thursday’s intra-day on the again of a disappointing set of numbers for March quarter (Q4FY22). The pharmaceutical company reported a consolidated lack of Rs 512 crore, on larger manufacturing value as towards a consolidated revenue of Rs 464 crore within the year-ago quarter (Q4FY21) and Rs 549 crore within the earlier quarter (Q3FY22).

The stock was at its lowest stage since April 2020. At 09:18 am, it was 7 per cent decrease at Rs 635.25, as in comparison with 1.9 per cent decline within the S&P BSE Sensex. Trading volumes on the counter more-than-doubled with a mixed 1.1 million shares having modified palms on the NSE and BSE until the time of writing of this report.

In This autumn, Lupin’s revenues grew 3 per cent year on year (YoY) to Rs 3,883 crore, whereby home formulations grew 5 per cent YoY to Rs 1,351 crore, whereas US revenues de-grew 5 per cent YoY to Rs 1,416 crore. Earnings earlier than curiosity, taxes, depreciation, and amortization (EBITDA) de-grew 68 per cent YoY to Rs 226 crore. EBITDA margin was down 1287 bps YoY at 5.8 per cent.

The administration mentioned the reported quarter was difficult with headwinds within the US on account of worth erosion, and inflation in enter supplies and freight. “We are focused on optimizing operating expenses and spend and ensuring the evolution of our complex generic platforms along with global portfolio maximization while doubling down on markets like India,” the administration mentioned.

“Lupin’s performance was skewed on revenues front amid US and India posting lower than expected sales while RoW and South Africa saw better than anticipated traction this quarter. Margins and profitability were a significant miss due to very high ex-R&D other expenditure (up 26 per cent YoY) and impairment charges of Rs 129 crore in respect of acquired IPs consequent to adverse market conditions,” ICICI Securities mentioned in a word.

The brokerage agency believes decision of warning letters and clearance of Official Action Indicated (OAIs) standing on crops may very well be the close to time period set off together with progress on the margins entrance.

Dear Reader,

Business Standard has at all times strived exhausting to supply up-to-date info and commentary on developments which are of curiosity to you and have wider political and financial implications for the nation and the world. Your encouragement and fixed suggestions on how one can enhance our providing have solely made our resolve and dedication to those beliefs stronger. Even throughout these troublesome instances arising out of Covid-19, we proceed to stay dedicated to preserving you knowledgeable and up to date with credible information, authoritative views and incisive commentary on topical problems with relevance.
We, nonetheless, have a request.

As we battle the financial affect of the pandemic, we want your assist much more, in order that we are able to proceed to give you extra high quality content material. Our subscription mannequin has seen an encouraging response from a lot of you, who’ve subscribed to our on-line content material. More subscription to our on-line content material can solely assist us obtain the objectives of providing you even higher and extra related content material. We consider in free, truthful and credible journalism. Your assist by extra subscriptions may help us practise the journalism to which we’re dedicated.

Support high quality journalism and subscribe to Business Standard.

Digital Editor

Back to top button